Vertex Pharmaceuticals Incorporated (0QZU)
LSE
Closed
Aug 24, 2026
Day's Range
541.9252 wk Range
375.33Overview - 0QZU - Vertex Pharmaceuticals Incorporated
Key Statistics
Valuation
Enterprise Value
133.32B
P/E (Trailing)
‪0.57‬
Price / Sales (TTM)
‪102.25‬
Price / Book
‪6.85‬
EV / EBITDA
‪26.13‬
Profitability
Profit Margin
‪34.99%‬
Operating Margin
‪38.05%‬
Return on Assets
‪11.92%‬
Return on Equity
‪23.54%‬
Ownership
Shares Outstanding
255.55M
Float
252.68M
Held by Insiders
‪0.21%‬
Held by Institutions
‪98.12%‬
Price stats
Beta
‪0.30‬
50-Day Avg
‪424.38‬
200-Day Avg
‪373.25‬
Dividends
Frequency
Semi-Annual
Market Cap - 0QZU - Vertex Pharmaceuticals Incorporated
Peers - 0QZU - Vertex Pharmaceuticals Incorporated
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
- 0QZULSEVertex Pharmaceuticals Incorporated140.34BMarket Cap+29.12%52-week change0.58P/E (Trailing)‪34.99%‬Profit Margin
- 0MGBLSEGenmab A/S173.69BMarket Cap+27.59%52-week change30.65P/E (Trailing)‪29.01%‬Profit Margin
- 0R2MLSERegeneron Pharmaceuticals, Inc.90.49BMarket Cap+31.55%52-week change0.12P/E (Trailing)‪27.86%‬Profit Margin
- 0A45LSEModerna, Inc.72.10BMarket Cap+82.56%52-week change55.34P/E (Trailing)‪11.32%‬Profit Margin
- 0QW0LSEargenx SE52.61BMarket Cap+34.75%52-week change42.42P/E (Trailing)‪-47.51%‬Profit Margin
- 0NZTLSEUCB SA44.92BMarket Cap+9.47%52-week change128.71P/E (Trailing)‪6.45%‬Profit Margin
- 0K91LSENorthern Trust Corporation40.97BMarket Cap+29.60%52-week change0.26P/E (Trailing)‪24.67%‬Profit Margin
Profile Summary - 0QZU - Vertex Pharmaceuticals Incorporated
About
Vertex Pharmaceuticals Incorporated is a global biopharmaceutical company headquartered in Boston, Massachusetts, specializing in the discovery, development, and commercialization of transformative medicines for patients with serious diseases. The company's primary focus centers on cystic fibrosis, where it has…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
